Cormorant Asset Management, LP 13D and 13G filings for Bright Minds Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-30 4:08 pm Sale | 2026-04-28 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management, LP | 950,000 9.710% | -109,331 (-10.32%) | Filing |
| 2026-02-06 3:00 pm Unchanged | 2026-01-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management, LP | 1,059,331 10.880% | 0 (Unchanged) | Filing |
| 2024-11-06 4:06 pm Purchase | 2024-11-04 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management, LP | 1,059,331 17.260% | 184,331 (+21.07%) | Filing |
| 2024-10-22 4:03 pm Purchase | 2024-10-15 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management, LP | 875,000 18.790% | 875,000 (New Position) | Filing |